PharmD: University of Iowa
PGY1: University of Wisconsin Health
PGY2 Oncology/Hematology: University of Wisconsin Health
Acute leukemias, treatment of leukemia in the adolescent and young adult population, quality improvement and pharmacy practice advancement
Hematology/Oncology Pharmacy Association (HOPA)
American Society of Health-System Pharmacists (ASHP)
Schmiegelow K, Rank CU, Stock W, Dworkin E, van der Sluis I. SOHO State of the art updates and next questions: management of asparaginase toxicity in adolescents and young adults with acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2021;21(11):725-733.
Patel AA, Heng J, Dworkin E, Monick S, Derman B, et al. Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults. eJHaem. Published online June 2021.
Schulz LT, Dworkin E, Dela-Pena J, Rose WE. Multiple-dose oritavancin evaluation in a retrospective cohort of patients with complicated infections. Pharmacotherapy. 2018;38(1):152-159.
Dworkin E, Hager D. Taking the fear out of feedback: models for success. J Pharm Soc Wis.2016;19(2):22-25.
Academic and/or National Presentations
Optimal intensive induction for older adults with newly diagnosed acute myeloid leukemia. Presented at the Hematology/Oncology Pharmacy Association Annual Conference. Boston, MA. April 2022
Checkpoint inhibitors in hematologic malignancies. Recorded Lecture for The Hematology/Oncology Pharmacy Association 2021 BCOP Oncology Pharmacy Updates
Advances in targeted therapy for AML: Practical management of BCL-2 inhibitors. Abbvie Sponsored Symposium. Presented at The Hematology/Oncology Pharmacy Association Annual Conference. [Virtual] April 2021
Off label prescribing of novel agents in acute myeloid leukemia, with Jordan Baur, PharmD
The impact of a pharmacist driven protocol for management of 6MP and oral MTX during AML maintenance therapy with Kaitlin Kelly, PharmD, BCOP